SIM
COGT icon

Sandia Investment Management’s Cogent Biosciences COGT Stock Holding History

Sandia Investment Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$35.5K Sell
1,000
-14,000
-93% -$394K 0.09% 110
2025
Q3 		$215K Buy
+15,000
New +$178K 0.64% 58
2024
Q1 		– Sell
-5,980
Closed -$35.2K – 140
2023
Q4 		$35.2K Sell
5,980
-4,020
-40% -$30.8K 0.02% 134
2023
Q3 		$97.5K Hold
10,000
– – 0.03% 151
2023
Q2 		$118K Buy
+10,000
New +$115K 0.03% 148

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sandia Investment Management's COGT Position: Q4 2025 in Review

Sandia Investment Management reduced its Cogent Biosciences (COGT) stake by 93% in Q4 2025, selling an estimated $394K and leaving 1,000 shares worth $35.5K. The position accounts for 0.09% of the portfolio, ranked #110.

Sandia Investment Management first reported a position in COGT in Q2 2023 and has held it in 5 quarters since. The position peaked at $215K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Sandia Investment Management held 1,000 shares of Cogent Biosciences worth $35.5K as of Q4 2025.
  • Sandia Investment Management sold 14,000 Cogent Biosciences shares in Q4 2025, an estimated $394K.
  • Cogent Biosciences made up 0.09% of Sandia Investment Management's portfolio in Q4 2025, its #110 holding.
  • Sandia Investment Management first reported a position in Cogent Biosciences in Q2 2023 and has held it in 5 quarters since.
  • Sandia Investment Management's Cogent Biosciences position peaked at $215K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.